The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Contaminated food is causing a growing number of illnesses in the United States, and severe cases that lead to ...

Edward Haynes reveals how advanced sequencing technologies are assisting food companies in their mission to deliver quality ...

President and CEO Katherine Stueland stated that GeneDx achieved significant milestones in 2024, including surpassing $95 million in Q4 revenue and expanding gross margins to 70%. She highlighted the ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Whole genome sequencing can be an exceptionally valuable tool in cancer diagnostics. The application of this technique can ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

New developments in genome-scanning technologies and computational methodologies, and the availability of a reference sequence for comparison, have made possible the large-scale discovery of ...

The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

GAITHERSBURG, Md. - GeneDx (NASDAQ:WGS), a genomic insights company with a market capitalization of $1.95 billion, announced the introduction of its ultraRapid Whole Genome Sequencing service, which ...